IMO, Ignore the KZA low share volume traded today.. AU$40K value traded to reduce the Kazia Market Capital by AU$4.8M.
China GBM AGILE study to commence recruiting patients soon, which should trigger a Simcere milestone payment to cover 2022/23 cash requirements.
Watch & listen to the video 8 June 2022, as James Garner mentions the various trial imminent data releases.
xxx xxxxxx xxxxxxxxx = pro active investors (one word) just in case HotCopper modifies.
do not advertise external links.au/companies/news/984279/kazia-onto-next-chapter-in-phase-2-brain-metastases-trial-984279.html
Regards.
- Forums
- ASX - By Stock
- KZA
- Memorial Sloan Results Imminent
Memorial Sloan Results Imminent, page-33
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)